164 related articles for article (PubMed ID: 28165808)
1. Plasma concentration of metformin and dexamethasone after administration through Osseogate.
Kim HK; Park YS
Drug Deliv; 2017 Nov; 24(1):437-442. PubMed ID: 28165808
[TBL] [Abstract][Full Text] [Related]
2. Release pattern of dexamethasone after administration through an implant-mediated drug delivery device with an active plunger of super absorbent polymer.
Yang ST; Park YS
Drug Deliv Transl Res; 2018 Jun; 8(3):702-707. PubMed ID: 29626335
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone Delivery by an Implant-Mediated Drug Delivery System in the Canine Mandible.
Park JH; Cha HS; Kim HK; Park YS
J Periodontol; 2016 Jun; 87(6):700-5. PubMed ID: 26751343
[TBL] [Abstract][Full Text] [Related]
4. The Sustained Effects on Tear Volume of Pilocarpine Hydrochloride in Gelatin by Hydrogel Administered by An Implant-mediated Drug Delivery System.
Cha S; Kim HK; Kho HS; Park YS
Curr Drug Deliv; 2017; 14(4):581-586. PubMed ID: 27739377
[TBL] [Abstract][Full Text] [Related]
5. Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system.
Park YS; Cho JY; Lee SJ; Hwang CI
Biomed Res Int; 2014; 2014():801358. PubMed ID: 25136624
[TBL] [Abstract][Full Text] [Related]
6. Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery.
Battiston K; Parrag I; Statham M; Louka D; Fischer H; Mackey G; Daley A; Gu F; Baldwin E; Yang B; Muirhead B; Hicks EA; Sheardown H; Kalachev L; Crean C; Edelman J; Santerre JP; Naimark W
Nat Commun; 2021 May; 12(1):2875. PubMed ID: 34001908
[TBL] [Abstract][Full Text] [Related]
7. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema.
Daull P; Paterson CA; Kuppermann BD; Garrigue JS
J Ocul Pharmacol Ther; 2013 Mar; 29(2):258-69. PubMed ID: 23331052
[TBL] [Abstract][Full Text] [Related]
8. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system.
Hasan AA; Madkor H; Wageh S
Drug Deliv; 2013; 20(3-4):120-6. PubMed ID: 23651102
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone Degradation in Aqueous Medium and Implications for Correction of In Vitro Release from Sustained Release Delivery Systems.
Matter B; Ghaffari A; Bourne D; Wang Y; Choi S; Kompella UB
AAPS PharmSciTech; 2019 Oct; 20(8):320. PubMed ID: 31646399
[TBL] [Abstract][Full Text] [Related]
11. An in vivo pharmacokinetic study of metformin microparticles as an oral sustained release formulation in rabbits.
Bouriche S; Alonso-García A; Cárceles-Rodríguez CM; Rezgui F; Fernández-Varón E
BMC Vet Res; 2021 Sep; 17(1):315. PubMed ID: 34563196
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study.
Fialho SL; Behar-Cohen F; Silva-Cunha A
Eur J Pharm Biopharm; 2008 Mar; 68(3):637-46. PubMed ID: 17851057
[TBL] [Abstract][Full Text] [Related]
13. Transdermal Cubic Phases of Metformin Hydrochloride: In Silico and in Vitro Studies of Delivery Mechanisms.
Yu X; Jin Y; Du L; Sun M; Wang J; Li Q; Zhang X; Gao Z; Ding P
Mol Pharm; 2018 Aug; 15(8):3121-3132. PubMed ID: 29979604
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
15. Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery.
Thalhauser S; Peterhoff D; Wagner R; Breunig M
Eur J Pharm Biopharm; 2020 Nov; 156():1-10. PubMed ID: 32860903
[TBL] [Abstract][Full Text] [Related]
16. Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 3(2) full factorial design.
Boldhane SP; Kuchekar BS
Curr Drug Deliv; 2009 Oct; 6(5):477-85. PubMed ID: 19863493
[TBL] [Abstract][Full Text] [Related]
17. Manufacturing of Dexamethasone-Poly(d,l-Lactide-co-Glycolide) Implants Using Hot-Melt Extrusion: Within- and Between-Batch Product Performance Comparisons.
Kelley RA; Ghaffari A; Wang Y; Choi S; Taylor JR; Hartman RR; Kompella UB
J Ocul Pharmacol Ther; 2020 Jun; 36(5):290-297. PubMed ID: 32330403
[No Abstract] [Full Text] [Related]
18. Topical sustained drug delivery to the retina with a drug-eluting contact lens.
Ross AE; Bengani LC; Tulsan R; Maidana DE; Salvador-Culla B; Kobashi H; Kolovou PE; Zhai H; Taghizadeh K; Kuang L; Mehta M; Vavvas DG; Kohane DS; Ciolino JB
Biomaterials; 2019 Oct; 217():119285. PubMed ID: 31299627
[TBL] [Abstract][Full Text] [Related]
19. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: preparation and in vitro/in vivo evaluation.
He W; Li Y; Zhang R; Wu Z; Yin L
Int J Pharm; 2014 Dec; 476(1-2):223-31. PubMed ID: 25283698
[TBL] [Abstract][Full Text] [Related]
20. Potential Enhancement of Metformin Hydrochloride in Lipid Vesicles Targeting Therapeutic Efficacy in Diabetic Treatment.
Ossai EC; Madueke AC; Amadi BE; Ogugofor MO; Momoh AM; Okpala COR; Anosike CA; Njoku OU
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
